RxDoctor Payments Data

Margaret Zhou, MD

Gastroenterology · Stanford, CANPI 1184157992

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $241,601 of the $287,935 with a category attached, or 83.9%. Capsovision, Inc. accounts for 83.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $163,013, more than ten times the $122 reported in 2021. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$287,935in general payments, 2019–2025

Across 79 payments — averaging $3644.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Capsovision, Inc.$242K
  • Boston Scientific$42K
  • Olympus Corporation Of The Americas$2K
  • Ovesco Endoscopy USA, Inc.$876
  • Creo Medical Inc.$426
  • ERBE USA Inc$205
  • plus $738 from 6 others

What the payments were for

  • Consulting fees$241,60184%
  • Grants$37,50013%
  • Travel & lodging$6,1692%
  • Food & beverage$2,4271%
  • Education$2390%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Capsovision, Inc.18$241,601
Boston Scientific34$41,942
Olympus Corporation Of The Americas15$2,147
Ovesco Endoscopy USA, Inc.1$876
Creo Medical Inc.2$426
ERBE USA Inc1$205
Medtronic3$158
Olympus America Inc.1$138
Lucid Diagnostics Inc.1$124
AbbVie1$122
Aadi Bioscience, Inc.1$105
Steris Corporation1$92

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$287,935 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$34,004
Medicare patients
112
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg25$508
Omeprazole21$220
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl11$216

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →